(Q36271648)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

review article

1 reference

title

Safety and potential of drug interactions of caspofungin and voriconazole in multimorbid patients (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

Vanessa Kulemann

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Wolfgang Graninger

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

Christian Joukhadar

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

publication date

28 September 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

75

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

165-178

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

Interventional antimicrobial therapy in febrile neutropenic patients

7 January 2020

cites work

1 reference

Prevention and therapy of fungal infections in cancer patients. A review of recently published information

21 January 2018

1 reference

Amphotericin B nephrotoxicity

21 January 2018

1 reference

The epidemiology of nephrotoxicity associated with conventional amphotericin B therapy

21 January 2018

1 reference

Changing strategies for the management of invasive fungal infections

21 January 2018

1 reference

Comparison of effects of amphotericin B deoxycholate infused over 4 or 24 hours: randomised controlled trial

21 January 2018

1 reference

Oral fluconazole for empiric treatment of prolonged Fever in neutropenic patients: prospective study in 250 consecutive patients after stem cell transplantation

21 January 2018

1 reference

Prevention of invasive fungal infections in patients with neoplastic disease

21 January 2018

1 reference

21 January 2018

1 reference

Voriconazole: a new triazole antifungal agent

21 January 2018

1 reference

Practice guidelines for the treatment of fungal infections. For the Mycoses Study Group. Infectious Diseases Society of America

21 January 2018

1 reference

Caspofungin: an echinocandin antifungal agent

21 January 2018

1 reference

Voriconazole in the treatment of aspergillosis, scedosporiosis and other invasive fungal infections in children

21 January 2018

1 reference

Activities of caspofungin, itraconazole, posaconazole, ravuconazole, voriconazole, and amphotericin B against 448 recent clinical isolates of filamentous fungi

21 January 2018

1 reference

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

21 January 2018

1 reference

Safety and pharmacokinetics of oral voriconazole in patients at risk of fungal infection: a dose escalation study

21 January 2018

1 reference

Comparison of caspofungin and amphotericin B for invasive candidiasis

21 January 2018

1 reference

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

21 January 2018

1 reference

Single- and multiple-dose pharmacokinetics of caspofungin in healthy men.

21 January 2018

1 reference

Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration

21 January 2018

1 reference

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

21 January 2018

1 reference

Safety and efficacy of caspofungin and liposomal amphotericin B, followed by voriconazole in young patients affected by refractory invasive mycosis

21 January 2018

1 reference

A comparative study of the post-antifungal effect (PAFE) of amphotericin B, triazoles and echinocandins on Aspergillus fumigatus and Candida albicans

21 January 2018

1 reference

Review of the safety, tolerability, and drug interactions of the new antifungal agents caspofungin and voriconazole

21 January 2018

1 reference

Echinocandins and pneumocandins--a new antifungal class with a novel mode of action

21 January 2018

1 reference

Caspofungin: the first in a new class of antifungal agents

21 January 2018

1 reference

A new era of antifungal therapy

21 January 2018

1 reference

Caspofungin: the first representative of a new antifungal class.

21 January 2018

1 reference

Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia

21 January 2018

1 reference

Disposition of caspofungin: role of distribution in determining pharmacokinetics in plasma

21 January 2018

1 reference

Salvage therapy with caspofungin for invasive aspergillosis: results from the caspofungin compassionate use study

21 January 2018

1 reference

Efficacy and safety of caspofungin for treatment of invasive aspergillosis in patients refractory to or intolerant of conventional antifungal therapy

21 January 2018

1 reference

Potential for interactions between caspofungin and nelfinavir or rifampin

21 January 2018

1 reference

21 January 2018

1 reference

A randomized, double-blind, double-dummy, multicenter trial of voriconazole and fluconazole in the treatment of esophageal candidiasis in immunocompromised patients

21 January 2018

1 reference

Efficacy and safety of voriconazole in the treatment of acute invasive aspergillosis

21 January 2018

1 reference

Voriconazole concentrations in the cerebrospinal fluid and brain tissue of guinea pigs and immunocompromised patients

21 January 2018

1 reference

Adverse reactions to voriconazole.

21 January 2018

1 reference

Dosage recommendation of phenytoin for patients with epilepsy with different CYP2C9/CYP2C19 polymorphisms

21 January 2018

1 reference

Coadministration of voriconazole and phenytoin: pharmacokinetic interaction, safety, and toleration

21 January 2018

1 reference

No clinically significant pharmacokinetic interactions between voriconazole and indinavir in healthy volunteers

21 January 2018

1 reference

Voriconazole potentiates warfarin‐induced prothrombin time prolongation

21 January 2018

1 reference

Effect of omeprazole on the steady‐state pharmacokinetics of voriconazole

21 January 2018

1 reference

The influence of St John's Wort on CYP2C19 activity with respect to genotype

21 January 2018

1 reference

Molecular epidemiology of Candida

21 January 2018

1 reference

Prophylaxis and treatment of invasive candidiasis in the intensive care setting

21 January 2018

1 reference

Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America

21 January 2018

1 reference

Long-term benefits of highly active antiretroviral therapy in Senegalese HIV-1-infected adults

21 January 2018

1 reference

Six-year follow-up of HIV-1-infected adults in a clinical trial of antiretroviral therapy with indinavir, zidovudine, and lamivudine

21 January 2018

1 reference

No clinically significant effect of erythromycin or azithromycin on the pharmacokinetics of voriconazole in healthy male volunteers

21 January 2018

1 reference

A randomized double-blind study of caspofungin versus fluconazole for the treatment of esophageal candidiasis

21 January 2018

1 reference

Clinical relevance of sirolimus drug interactions in transplant patients

21 January 2018

1 reference

Voriconazole in the treatment of invasive mold infections in transplant recipients.

21 January 2018

1 reference

Combined use of sirolimus and voriconazole in renal transplantation: a report of two cases.

21 January 2018

1 reference

Effect of voriconazole on the pharmacokinetics of cyclosporine in renal transplant patients

21 January 2018

1 reference

Cytochrome P450 3A polymorphisms and immunosuppressive drugs

21 January 2018

1 reference

Safety of the concomitant use of caspofungin and cyclosporin A in patients with invasive fungal infections

21 January 2018

1 reference

Retrospective study of the hepatic safety profile of patients concomitantly treated with caspofungin and cyclosporin A.

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000088622

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16192747%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference